A new study finds that ursodeoxycholic acid (UDCA) effectively dissolves gallstones in 60% of patients after sleeve ...

ATOPIC dermatitis (AD) is a chronic inflammatory skin condition that significantly impacts patients’ quality of life. It is ...

Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

A phase 3 trial confirms delgocitinib cream is safe and effective for long-term treatment of chronic hand eczema, maintaining disease control for up to 52 weeks.

Experts stress the need for diversity in basic and clinical research, highlighting recruitment challenges, mentorship gaps, ...

A recent study reveals that nearly half of family surrogate decision-makers for stroke patients face substantial financial ...

Preliminary results from the MITO 40 study presented at ESGO 2025 suggest Niraparib as a promising maintenance treatment for ...

A LARGE cohort study of 221,054 US adults has revealed that higher butter intake is associated with increased mortality, ...

BLADDER cancer is classified as either non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC) ...

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.

Study presented at ESGO 2025 highlights the accuracy of preoperative tumour size assessment in stage IB2 cervical cancer and ...